ArticleCurrent pharmaceutical biotechnology2025

Development and Characterization of an Anti-PD-L1 Immunotoxin for Targeted Cancer Therapy.

Ali Takhteh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.